treatment of four individuals with acute lymphoblastic leukemia with the adenosine deaminase inhibitor , 2'-deoxycoformycin , resulted in elevations in plasma deoxyadenosine concentrations and in increments in lymphoblast datp levels that were similar to those measured in lymphoblasts cultured with deoxyadenosine and deoxycoformycin prior to treatment .
C0023449
acute lymphoblastic leukemia
C0229613
datp